glucagon-like peptide-1

News

Serena Williams opens up on using weight loss medication

Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be’

Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Fox News on MSN · 13h

Serena Williams opens up about 31-pound weight loss using GLP-1 medication: ‘Something I suffered with’

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose weight following the birth of her two daughters.

The State Journal · 3d

Pros and cons of new GLP-1 weight loss/diabetes drugs

Most people have likely heard about the new weight-loss and diabetes management drugs called Ozempic and Mounjaro, which are also called GLP-1 medications, short for glucagon-like peptide-1 agonists,

The American Journal of Managed Care6d

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

3don MSN

GLP-1 drugs linked to reduced symptoms in chronic skin condition hidradenitis suppurativa

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

ConsumerAffairs13d

GLP-1 use surges among perimenopausal women but research hasn't kept up

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...

Managed Healthcare Executive2d

GLP-1 Medications Show Promise in Treating Hidradenitis Suppurativa

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

The American Journal of Managed Care1d

Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia

Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and ...

National Academies of Sciences%2c Engineering%2c and Medicine11mon

Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for ...

Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have ...

Morgenpost13y

Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced ...

Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors 28.11.2011, 07:01 Uhr • Lesezeit: 9 Minuten ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results